The Peptide Report
A head-to-head comparison of SLU-PP-332 and Cardarine (GW501516), two compounds often called 'exercise in a pill.' We break down mechanism, safety profile, and which option is the more transparent choice in 2026.
Cardarine promised 'exercise in a pill' over a decade ago — but cancer signal concerns shelved it. Now SLU-PP-332, a next-generation ERR agonist, is rewriting the exercise mimetic playbook. Here's how they really compare.
